Abbreviations
- ACE:
-
Angiotensin converting enzyme
- AKI:
-
Acute kidney injury
- ARB:
-
Angiotensin receptor blocker
- BMI:
-
Body mass index
- CCB:
-
Calcium channel blocker
- CKD:
-
Chronic kidney disease
- CVD:
-
Cardiovascular disease
- eGFR:
-
Estimated glomerular filtration rate
- ESKD:
-
End-stage kidney disease
- GNRI:
-
Geriatric nutritional risk index
- QOL:
-
Quality of life
- RAS:
-
Renin angiotensin system
Acknowledgements
Production of these guidelines was supported by a Grant-in-Aid for Research on Advanced Chronic Kidney Disease, Practical Research Project for Renal Diseases from the Japan Agency for Medical Research and Development, AMED.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
All committee members involved in producing this guideline submitted conflict-of-interest statements based on the AMED rules.
Additional information
Research team for a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Diseases from Japan Agency for Medical Research and Development, AMED published Clinical Practice Guidelines for CKD stage G3b-5 2017 (in Japanese) in Journal of Japanese Society of Nephrology (in press). This is the English, digest version of that guideline.
About this article
Cite this article
Okada, H., Research Team for a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J). & Practical Research Project for Renal Diseases from Japan Agency for Medical Research and Development, AMED. Essentials from clinical practice guidelines for CKD stage G3b-5 2017. Clin Exp Nephrol 22, 245–248 (2018). https://doi.org/10.1007/s10157-018-1532-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-018-1532-z